Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 03/16/15
End: 01/12/18
Due: 01/12/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety Study of X-82 in Patients With Advanced Solid Tumors | NCT01296581 | Tyrogenex | user2@example.com | None | 2011-02-28 | 2017-01-31 | 2018-01-31 | - | - | 2025-07-14 |
| Pilot Study of X-82 in Patients With Wet AMD | NCT01674569 | Tyrogenex | user2@example.com | None | 2012-10-31 | 2015-02-28 | 2016-02-28 | - | - | 2025-07-14 |
| X-82 to Treat Age-related Macular Degeneration | NCT02348359 | Tyrogenex | user2@example.com | None | 2015-03-16 | 2018-01-12 | 2019-01-12 | - | - | 2025-07-14 |